Last updated: November 14, 2024

Overview

A cataract is an opacity of the crystalline lens. It causes haziness and cloudiness of vision. It is a painless process. It is treated by surgery.

  • Common risk factors
    • Older age
    • Smoking
    • Alcohol
    • Excessive sunlight
    • Long-term corticosteroid use
    • Eye trauma and infection
    • Diabetes
Senile Cataract
Vision in a patient with cataracts. Source: Grace and Vision Optometrists

Leukocoria

Leukocoria can be a presenting sign of cataracts. It appears as a “white pupil” on gross examination or via examination with an ophthalmoscope (with a lack of red reflex). Leukocoria in infants and children is alarming and is a medical emergency since it may indicate retinoblastoma.

  • Differentials for leukocoria
    • Retinoblastoma
    • Congenital cataract
    • Retinal malformation
    • Retinopathy of prematurity
    • Retinal detachment
    • Intraocular infeciton

Congenital Cataract

Congenital cataracts are a major cause of vision loss in children worldwide and are the most common cause of leukocoria in children. The morphology of cataracts can provide clues towards the possible cause.

1/3 of congenital cataracts are hereditary. Another 1/3 is due to infection or congenital syndrome (Down syndrome, Alport syndrome). The remaining 1/3 is idiopathic.

  • Causes of congenital cataracts
    • Infectious (TORCH)
      • Toxoplasmosis
      • Other: Syphilis, Parvovirus B19
      • Rubella: classically develop cataracts
      • CMV
      • HSV, HIV
    • Genetic/metabolic errors (tend to have bilateral cataracts)
      • Down syndrome
      • Galactosemia (NBS)
      • Lowe’s syndrome (urine calcium, phosphorus, amino acids)
      • Alport’s syndrome (hearing deficit, renal impairment, X-linked)
      • Fabry’s disease (skin manifestations, renal impairment, X-linked)
      • Coat’s disease (unilateral, presents older, gradual vision loss)
  • Pathophysiology of cataracts in galactosemia
    • Aldose reductase is an enzyme involved in the polyol pathway that is involved in the breakdown of:
      • Glucose to sorbitol
      • Galactose to galactitol
    • This enzyme normally has low levels of activity in the lens
    • In galactosemia, the high galactose levels activate aldose reductase in the lens which increases the levels of galactitol produced
    • Galactitol accumulates in the lens and draws in fluid leading to increased lens osmolarity which results in cataract formation
  • Signs and symptoms
    • Leukocoria
    • Absent red reflex (unilateral or bilateral)
    • Nystagmus
    • The child may be unaware of visual surroundings (especially if bilateral)
  • Investigations
    • Ophthalmologic
      • Slit lamp examination
      • Dilated fundoscopic examination
    • Laboratory
      • TORCH titers (Toxoplasmosis, CMV, VDRL)
      • Urine for amino acids, phosphates, calcium
      • Other routine labs (CBC, UECs)
  • Treatment
    • Surgical removal (no later than 3 months of age)
    • Followup with ophthalmology and optometry
    • Genetic counseling if appropriate
  • Complications of congenital cataracts
    • Deprivation amblyopia
    • Strabismus
    • Blindness

Senile Cataract

Senile cataracts occur with age and are the leading cause of blindness worldwide. Cataracts are reversible. However, the lens can begin to irreversibly thicken as the cataract matures.

Mature cataract: The patient cannot read better than 20/200 (6/60)

Immature cataract: The patient cannot see better than 20/20 (6/6)

Incipient cataract: The patient can see 20/20 (6/6)

Most patients over 60 years of age have some degree of cataract.

Types of cataracts and their morphologies. An intraocular lens (IOL) can be implanted after cataract surgery.
  • Risk factors
  • Pathophysiology of cataracts in diabetes
    • Aldose reductase is an enzyme involved in the polyol pathway that is involved in the breakdown of:
      • Glucose to sorbitol
      • Galactose to galactitol
    • This enzyme normally has low levels of activity in the lens
    • In diabetes, the high glucose levels activate aldose reductase in the lens which increases the levels of sorbitol produced
    • Sorbitol accumulates in the lens and draws in fluid leading to increased lens osmolarity which results in cataract formation
  • Signs and symptoms
    • Visual impairment (chief complaint)
    • Leukocoria
    • Glare/halos
    • Myopic shift (increase in the convergence power of the lens. Ask the patient whether they are using their reading glasses as much as they did before)
    • Monocular diplopia (a double vision that does not go away when you cover one eye)
  • Physical examination Examined in a brightly lit room
    • Ophthalmoscopic exam
    • Slit-lamp examination (for a formal and more precise diagnosis)
  • Investigations Assess for possible concurrent illnesses that can contribute to cataract formation
    • Random Blood Glucose, Fasting blood glucose, HbA1C
    • Lipid panel
  • Treatment
    • Surgical removal by an ophthalmologist
  • Prognosis
    • 95% of adults have increased visual acuity following surgery

Other causes of Cataracts in adults

  • Ocular trauma
  • Radiation
  • Adverse effects of corticosteroids, antipsychotics (Quetiapine)
  • Skin diseases: Atopic dermatitis, Eczema
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *